Zealand Pharma A/S (CPH: ZEAL)
Denmark
· Delayed Price · Currency is DKK
726.50
-1.50 (-0.21%)
Jan 30, 2025, 4:10 PM CET
Zealand Pharma Revenue
Zealand Pharma had revenue of 4.42M DKK in the quarter ending September 30, 2024, a decrease of -98.51%. This brings the company's revenue in the last twelve months to 76.87M, down -77.62% year-over-year. In the year 2023, Zealand Pharma had annual revenue of 342.79M with 229.65% growth.
Revenue (ttm)
76.87M
Revenue Growth
-77.62%
P/S Ratio
n/a
Revenue / Employee
257.95K
Employees
253
Market Cap
51.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
Dec 31, 2019 | 41.33M | 3.36M | 8.84% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 270.58B |
Coloplast | 27.03B |
Genmab | 19.84B |
Demant | 22.84B |
H. Lundbeck | 21.44B |
Ambu A/S | 5.39B |
ALK-Abelló | 5.38B |
GN Store Nord | 18.04B |
Zealand Pharma News
- 16 days ago - Zealand CEO on navigating the obesity space among the two biggest players - CNBC
- 17 days ago - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons - GlobeNewsWire
- 23 days ago - Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity - GlobeNewsWire
- 24 days ago - Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th - GlobeNewsWire
- 5 weeks ago - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons - GlobeNewsWire
- 5 weeks ago - Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. - GlobeNewsWire
- 5 weeks ago - Zealand Pharma CEO says Novo's CagriSema data supports monotherapy approach to cagrilintide - Reuters
- 5 weeks ago - FDA drug rejection hits Zealand Pharma shares - Financial Times